Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You must have been diagnosed with Fibromyalgia
- You must have been taking Duloxetine (60 mg per day) for at least 8 weeks
Who may not be able to join:
- You may not be able to join if you are pregnant
- You may not be able to join if you have been told by a doctor that you have kidney or liver problems, or if you have ever been on dialysis (a treatment that filters your blood when your kidneys cannot)
- You may not be able to join if you need an interpreter to communicate during the trial
- You may not be able to join if you have another ongoing illness (other than Fibromyalgia) that causes long-term pain and tiredness, such as cancer currently being treated with chemotherapy, Parkinson's disease, or Multiple Sclerosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jake Steenblick, DNP, University of Utah
Phone: 801-585-1216
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Duloxetine concentrations across metabolizer phenotypes, 3 groups; Measure inhibitors and inducers of CYP1A2 and CYP2D6 in blood sample
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.